Humanigen Inc (HGENQ)

[DonDonDonDon]

As an investor I was trying to be honest with myself about lenzilumab's chances at an EUA. The number I came up with is 95%. Lenzilumab met its primary endpoint. It did it for serious patients and there is no drug currently available that has good efficacy with severe patients. And then add to that Janet Woodcock being in control of OWS when lenz was chosen for government funding, I just don't see it getting rejected.

The data that Humanigen put out is for the entire trial. Other drugs are trying for an EUA based on slices of their trial. The best attack the hit pieces could come up with against lenz is that 33 patients were excluded from the trial because they didn't receive a dose. Why in the world would someone be included in the trial data if they didn't receive either lenzilumab or the placebo? And trial protocol excluded them from the beginning because that was the FDA guidance.

We've waited this long. We can wait a few more weeks. And now owning HGEN is almost stress free. Before the UK study confirming GM-CSF's role in Covid, I was super stressed. I was impressed with Chappell and Durrant but I was having to put a lot of faith in them. Then the UK study came out and I gained a ton of confidence that the trial would be a success. Now we've seen topline data. Data is great. Lenz will get an EUA. I have zero stress right now. The stock is virtually risk free.